Difficulties and Confusion Concerning the Management of Hypertensive Disorders in Pregnancy--Interpretation of the Guidelines for the Diagnosis and Treatment of Hypertensive Disorders in Pregnancy (2020)

LIN Jian-hua , LYU Xin

Abstract

Hypertensive disorder in pregnancy is a disease with diverse clinical manifestations. Herein, we provided interpretations for “The Guidelines for the Diagnosis and Treatment of Hypertensive Disorders in Pregnancy in China (2020 Edition)” and discussed the difficulties and confusion encountered in the management of hypertensive disorders in pregnancy in combination with clinical practice. Lowering blood pressure is the most important treatment and maintaining a stable target blood pressure can reduce damage to organ functions and is beneficial to fetal growth. When applying magnesium sulfate, attention should be paid to the indications and contraindications. Attention should be paid to hypoproteinemia in patients tested positive for proteinuria. There should be dynamic evaluation of the functions of maternal vital organs, fetal growth and development, fetal well-being and intrauterine safety, and determination of the appropriate timing of the termination of pregnancy, so as to ensure maternal and fetal safety. Attention should be paid to maternal high-risk factors, if early prediction and prevention are to be accomplished in order to reduce the incidence and severity of the disease.

 

Keywords: Hypertensive disorder in pregnancy, Preeclampsia, Interpretation of the guidelines

 

Full Text:

PDF


References


ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet Gynecol， 2019， 133(1): 1[2022-08-04]. https://doi. org/10.1097/AOG.0000000000003018.

American College of Obstetricians and Gynecologists， Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy. Obstet Gynecol，2013，122(5): 1122–1131.

MAGEE L A， PELS A， HELEWA M， et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: Executive summary. J Obstet Gynaecol Can，2014，36(7): 575–576.

BUTALIA S， AUDIBERT F， CÔTÉ A M， et al. Hypertension Canada's 2018 guidelines for the management of hypertension in pregnancy. Can J Cardiol，2018，34(5): 526–531.

WEBSTER K， FISHBURN S， MARESH M， et al. Diagnosis and management of hypertension in pregnancy: Summary of updated NICE guidance. BMJ， 2019， 366: l5119[2022-08-04]. https://doi.org/10.1136/bmj.l5119.

LOWE S A， BOWYER L， LUST K， et al. The SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014. Aust N Z J Obstet Gynaecol，2015，55(1): 11–16.

BROWN M A， MAGEE L A， KENNY L C， et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension，2018，72(1): 24–43.

POON L C， SHENNAN A， HYETT J A， et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet，2019，145 Suppl 1(Suppl 1): 1–33.

WHO recommendations: Policy of interventionist versus expectant management of severe pre-eclampsia before term. Geneva: World Health Organization， 2018.

LYU X， ZHANG W， ZHANG J， et al. Morbidity and maternal and infant outcomes of hypertensive disorder in pregnancy in China in 2018. J Clin Hypertens (Greenwich)，2021，23(6): 1194–1204.

MAGEE L A， NICOLAIDES K H， VON DADELSZEN P. Preeclampsia. N Engl J Med，2022，386(19): 1817–1832.


Refbacks

  • There are currently no refbacks.